Item Details

Reforming the Drug Compounding Regulatory Framework: Hearing Before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, First Session, July 16, 2013

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Format
Book; Government Document
Published
Washington : U.S. Government Printing Office, 2014.
Washington, District of Columbia : For sale by the Superintendent of Documents, U.S. Government Printing Office, [date of distribution not identified]
Language
English
SuDoc Number
Y 4.C 73/8:113-70
Description
vi, 190 pages ; 24 cm
Notes
  • Shipping list no.: 2015-0006-P.
  • "Serial No. 113-70."
  • Includes bibliographical references.
Technical Details
  • Access in Virgo Classic

  • LEADER 02491cam a2200541 i 4500
    001 u6423586
    003 SIRSI
    005 20141217114735.0
    008 141118s2014 dcu b f000 0 eng c
    010
      
      
    a| 2014406568
    035
      
      
    a| (OCoLC)890596865
    042
      
      
    a| pcc
    043
      
      
    a| n-us---
    040
      
      
    a| GPO b| eng e| rda c| GPO d| DLC d| GPO d| MvI
    049
      
      
    a| VA@@ a| VAL
    050
    1
    4
    a| KF27 b| .E553 2013v
    074
      
      
    a| 1019-A-01
    088
      
      
    a| Serial no. 113-70 (United States. Congress. House. Committee on Energy and Commerce)
    086
    0
      
    a| Y 4.C 73/8:113-70
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Energy and Commerce. b| Subcommittee on Health, e| author.
    245
    1
    0
    a| Reforming the drug compounding regulatory framework : b| hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, July 16, 2013.
    264
      
    1
    a| Washington : b| U.S. Government Printing Office, c| 2014.
    264
      
    2
    a| Washington, District of Columbia : b| For sale by the Superintendent of Documents, U.S. Government Printing Office, c| [date of distribution not identified]
    300
      
      
    a| vi, 190 pages ; c| 24 cm
    336
      
      
    a| text b| txt 2| rdacontent
    337
      
      
    a| unmediated b| n 2| rdamedia
    338
      
      
    a| volume b| nc 2| rdacarrier
    500
      
      
    a| Shipping list no.: 2015-0006-P.
    504
      
      
    a| Includes bibliographical references.
    500
      
      
    a| "Serial No. 113-70."
    650
      
    0
    a| Drugs x| Dosage forms z| United States.
    650
      
    0
    a| Pharmaceutical industry z| United States.
    650
      
    0
    a| Drug adulteration z| United States x| Prevention.
    655
      
    7
    a| Legislative hearings. 2| lcgft
    776
    0
    8
    i| Online version: a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. t| Reforming the drug compounding regulatory framework w| (OCoLC)887720599
    776
    0
    8
    i| Microfiche version: a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. t| Reforming the drug compounding regulatory framework w| (OCoLC)898145138
    596
      
      
    a| 2 17
    999
      
      
    a| Y 4.C 73/8:113-70 w| SUDOC i| X005136932 l| DOC-US m| ALDERMAN t| DOCUMENT
    999
      
      
    a| Y 4.C 73/8:113-70 w| SUDOC i| 35007100321144 l| LAW2-DOCS m| LAW t| DOCUMENT

Availability

Google Preview

Library Location Map Availability Call Number
Alderman US Documents (3 New) Map Available
Law 2nd Floor Documents Map Available